TTK Healthcare declares ₹10 dividend, reappoints chairman
TTK Healthcare Limited concluded its 68th AGM on July 26, 2026, with shareholders approving a ₹10 per share dividend and the reappointment of T T Raghunathan as Executive Chairman for five years. The board also adopted FY26 financial statements and ratified cost auditor fees for M/s Geeyes & Co. The virtual meeting featured engagement from shareholders and compliance with SEBI and MCA guidelines.
*this image is generated using AI for illustrative purposes only.
TTK Healthcare Limited shareholders approved a ₹10 per share dividend and the reappointment of T T Raghunathan as Executive Chairman at the company’s 68th Annual General Meeting (AGM) held on July 26, 2026. The meeting, conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM), also saw the adoption of audited financial statements for the year ended March 31, 2026, and the ratification of remuneration for cost auditors. The outcomes reflect continuity in leadership and consistent shareholder returns.
The AGM was chaired by Mr. T T Raghunathan, Executive Chairman, with Mrs. Gowry A Jaishankar, DGM – Legal & Company Secretary, overseeing proceedings in compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars. Mr. K Shankaran, Director, delivered the address on behalf of the Chairman. Since no adverse qualifications were present in the Auditor’s Report on Financial Statements for FY26, Section 145 of the Companies Act, 2013 did not require reading those comments aloud. Proxies were deemed unnecessary due to the absence of physical attendance.
Key Resolutions Passed
Shareholders approved five items of business through e-voting, with results determined by combining remote e-voting and votes cast during the AGM. The resolutions included ordinary resolutions for financial adoption, dividend declaration, director appointment, and cost auditor ratification, alongside a special resolution for the chairman’s reappointment.
| Item No. | Resolution Description | Type |
|---|---|---|
| 1 | Adoption of Audited Financial Statements for year ended March 31, 2026 | Ordinary |
| 2 | Declaration of Dividend of ₹10.00 per share (100%) on Equity Shares | Ordinary |
| 3 | Appointment of Mr. Krishnamurthy Shankaran (DIN: 00043205) as Director retiring by rotation | Ordinary |
| 4 | Reappointment of Mr. T T Raghunathan (DIN: 00043455) as Executive Chairman for 5 years from November 01, 2026 | Special |
| 5 | Ratification of remuneration payable to M/s Geeyes & Co., Cost Auditors, for financial year ending March 31, 2027 | Ordinary |
Engagement and Process Details
Thirteen out of nineteen registered speakers raised queries regarding company performance and operations, which were addressed by Mr. K Shankaran and Mr. S Kalyanaraman, Managing Director & CEO. The meeting commenced at 12:00 noon and concluded at 1:05 p.m. Electronic registers required under the Companies Act, 2013 were made available for inspection. The Scrutinizer’s Report and final voting results were scheduled for upload to the company website within two working days of the meeting’s conclusion.
Historical Stock Returns for TTK Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.42% | +5.94% | +13.76% | +8.48% | -22.61% | +31.91% |
How might the reappointment of T T Raghunathan for another five-year term influence TTK Healthcare's long-term strategic direction and market expansion plans?
Given the ₹10 per share dividend, what are analysts' expectations for future payout ratios and capital allocation strategies amidst current industry headwinds?
What specific operational or financial metrics from the FY26 audited statements drove shareholder confidence, and how do they compare to peer performance in the pharmaceutical sector?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
